Registration Statements and Prospectuses. (i) The offer and sale of the Common Shares as contemplated hereby complies with the requirements of Rule 415 under the Act. (ii) The Company has not, directly or indirectly, used or referred to any “free writing prospectus” (as defined in Rule 405 under the Act) except in compliance with Rules 164 and 433 under the Act.
Appears in 3 contracts
Sources: Preferred Stock Purchase Agreement (Revonergy Inc), Preferred Stock Purchase Agreement (Stem Cell Therapy International, Inc.), Preferred Stock Purchase Agreement (ImmunoCellular Therapeutics, Ltd.)